Should Biotechnology Stock Syros Pharmaceuticals Inc (SYRS) Be in Your Portfolio Tuesday?

Syros Pharmaceuticals Inc (SYRS) is around the middle of the Biotechnology industry according to InvestorsObserver. SYRS received an overall rating of 42, which means that it scores higher than 42 percent of all stocks. Syros Pharmaceuticals Inc also achieved a score of 41 in the Biotechnology industry, putting it above 41 percent of Biotechnology stocks. Biotechnology is ranked 40 out of the 148 industries.

SYRS has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on SYRS!

See Full SYRS Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Syros Pharmaceuticals Inc Stock Today?

Syros Pharmaceuticals Inc (SYRS) stock is trading at $5.10 as of 3:45 PM on Tuesday, Jan 31, a rise of $0.25, or 5.15% from the previous closing price of $4.85. The stock has traded between $4.84 and $5.39 so far today. Volume today is more active than usual. So far 237,007 shares have traded compared to average volume of 124,578 shares. Click Here to get the full Stock Report for Syros Pharmaceuticals Inc stock.